期刊文献+

抗癌液对人大肠癌裸小鼠移植瘤影响的实验研究 被引量:2

Experimental Study of Anti-Cancer Liquid on Human Colorectal Cancer Nude Mice Transplantation Tumor
下载PDF
导出
摘要 目的:观察抗癌液对人大肠癌裸小鼠移植瘤p53、血管内皮生长因子(vascular endothelial growth factor,VEGF)和表皮生长因子受体(epidermal growth factor receptor,EGFR)表达的影响。方法:建立人大肠癌裸小鼠移植瘤模型,随机分为空白组、氟尿嘧啶组、抗癌液组和抗癌液与氟尿嘧啶联合用药组(简称联合组)。造模成功后第3天开始给药,连续用药7 d。采用病理学免疫组化、图像分析技术比较各组移植瘤的p53、VEGF和EGFR表达情况。结果:抗癌液能抑制移植瘤生长,无论瘤质量还是体积均明显小于空白组(P<0.01),其抑瘤作用与氟尿嘧啶大致相当,联合组抑瘤作用与氟尿嘧啶组比较亦有显著性差异(P<0.01)。抗癌液组的VEGF表达较空白组减少(P<0.05),此种作用与氟尿嘧啶作用相当,联合用药后疗效优于氟尿嘧啶,且有显著性差异(P<0.05)。抗癌液组的EGFR表达较空白组减少(P<0.05),此种作用比氟尿嘧啶稍差,联合用药后疗效显著优于氟尿嘧啶(P<0.05)。抗癌液组的p53表达较空白组增加(P<0.05),此种作用比氟尿嘧啶作用稍差,但联合用药后疗效显著优于氟尿嘧啶(P<0.05)。结论:抗癌液对人大肠癌裸小鼠移植瘤有确切的抑瘤作用,其与氟尿嘧啶的抑瘤作用大致相当。抗癌液可有效调节VEGF、EGFR和p53的表达,与氟尿嘧啶联合应用具有协同增效作用。 Objective: To observe the effect of anti-cancer liquid on human colorectal cancer nude mice transplantation tumor p53,VEGF and EGFR expression. Methods: Establishment of human colorectal cancer nude mice transplantation tumor model and the rats were randomly divided into blank control group,5-FU group,anticancer solution group and anticancer liquid and fluorouracil plus medication group. After modeling success started 3 days to medicine,7 days of continuous use. Used the pathology immunohistochemistry,image analysis technology to compare transplantation tumor in each group of p53,vascular endothelial growth factor( VEGF) and epidermal growth factor receptor( EGFR) expression. Results: The anti-cancer liquid could inhibit the growth of transplanted tumor,both from the tumor weight and volume were significantly smaller than that of blank group( P〈0. 01),the tumor suppression effect and 5- Fu roughly,joint group of tumor suppression function compared with Fluorouracil injection group also had significant difference( P〈0. 01). The anti-cancer liquid group VEGF expression of reduction in the blank group( P〈0. 05),the effect was equal to the Fluorouracil injection,curative effect is better than that of Fluorouracil injection after combination,and significant difference( P〈0. 05). The anti-cancer liquid group EGFR expression of reduction in the blank group( P〈0. 05),and this effect than Fluorouracil injection was a bit poor,curative effect was better than that of Fluorouracil injection after combination( P〈0. 05). The anti-cancer liquid group of p53 expression increased in the blank group( P〈0. 05),the less than Fluorouracil injection,but after combination curative effect was better than that of Fluorouracil injection( P〈0. 05). Conclusion:The anti-cancer liquid on human colorectal cancer nude mice transplantation tumor has exactly tumor suppression effect,its inhibitory tumor with 5-Fu roughly equivalent. The anti-cancer liquid adjust the expression of VEGF,EGFR and P53. The anti-cancer liquid associated with Fluorouracil injection applications have synergy effect.
出处 《中医学报》 CAS 2016年第2期161-166,共6页 Acta Chinese Medicine
基金 国家中医药管理局科研基金项目--全国名老中医药专家传承工作室建设项目(201347)
关键词 大肠癌 移植瘤 抗癌液 免疫组化 P53 VEGF EGFR colorectal cancer transplantation tumor anti-cancer liquid immunohistochemistry p53 VEGF EGFR
  • 相关文献

参考文献16

  • 1李世荣.实用结直肠癌外科学[M].北京:人民卫生出版社,2012:80-92.
  • 2Seiji O,Kitadai Y,Tanaka S,et al.Expression of VEGF-C and VEGF-D at theinvasive edge correlates with lymph node metastasis and prognosis of patients withcolorectal carcinoma[J].Cancer Sci,2004,95(1):32-39.
  • 3邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206
  • 4Parr C,Jiang WG.Quantitative analysis of lymphangiogenic markers in human colorectal cancer[J].Int J Oncol,2003,23(2):533-539.
  • 5Giantonio BJ,Catalano PJ,Meropol NJ,et al.High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer:results from the Eastern Cooperative Oncology Group(ECOG)study 3 200[J].J Clin Oncol,2005,23(1):1.
  • 6Harris CC.p53 Tumor suppressor gene:from Ihe basic research laboratory to the clinic-an abridged historical perspective[J].Carcinogenesis,1998,17(12):1187-1198.
  • 7呼闯营,贺彩峰.TGF-α和EGFR在Barrett食管和食管腺癌的表达[J].世界华人消化杂志,2006,14(9):879-883. 被引量:7
  • 8刘国龙,张万岱,宋于刚,周殿元.大肠癌组织中表皮生长因子受体的定量检测[J].胃肠病学和肝病学杂志,1994,3(4):250-251. 被引量:1
  • 9Oda K,Arakawa H,Tanaka T,et al.p53A IP1,a potertialm ediator ofp53-dependent apoptosis,and its regulationby Ser-46-phosphorylated p53[J].Cell,2000,102(6):849-862.
  • 10Baker SJ,Markowitz S,Fearon ER,et al.Suppression of human colorectal carcinoma cell growth by wild-type p53[J].Science,1990,(4971):912-915.

二级参考文献11

共引文献228

同被引文献29

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部